Xingxin New Materials (001358.SZ) stated on the investor interaction platform on June 14 that the company's N-hydroxyethylpiperazine product has strong competitiveness and a certain market share in China; At present, the company has no cooperation with enterprises related to lithography machines; the company will increase its research and development investment in piperazine and its derivatives in the future.
兴欣新材(001358.SZ)：目前公司没有和光刻机相关企业有合作
Xingxin New Material (001358.SZ): Currently, the company has no cooperation with lithography-related enterprises.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.